Global Breast Implants Pipeline Research Report 2023: Sizers, Expanders, Premium Round Gel Implants, Round Gel Implants, Saline Implants and Shaped Gel Implants


Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

"Breast Implants Pipeline Report' provides comprehensive information about the Breast Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Breast Implants includes the Sizers, Expanders, Premium round gel Implants, Round gel Implants, Saline Implants and Shaped gel Implants.

Scope

  • Extensive coverage of the Breast Implants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Implants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Implants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Breast Implants Overview

3 Products under Development
3.1 Breast Implants - Pipeline Products by Stage of Development
3.2 Breast Implants - Pipeline Products by Segment
3.3 Breast Implants - Pipeline Products by Territory
3.4 Breast Implants - Pipeline Products by Regulatory Path
3.5 Breast Implants - Pipeline Products by Estimated Approval Date
3.6 Breast Implants - Ongoing Clinical Trials

4 Breast Implants - Pipeline Products under Development by Companies
4.1 Breast Implants Companies - Pipeline Products by Stage of Development
4.2 Breast Implants - Pipeline Products by Stage of Development

5 Breast Implants Companies and Product Overview
5.1 3D Bio Corp Company Overview
5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allergan Aesthetics Company Overview
5.3 Apex Medical Device Design LLC Company Overview
5.4 Arula Technolgies Company Overview
5.5 BellaSeno GmbH Company Overview
5.6 BellaSeno Pty Ltd Company Overview
5.7 Biostruxs LLC Company Overview
5.8 Collplant Biotechnologies Ltd Company Overview
5.9 Establishment Labs SA Company Overview
5.10 FixNip Ltd Company Overview
5.11 GC Aesthetics Plc Company Overview
5.12 HansBiomed Co Ltd Company Overview
5.13 Healshape SAS Company Overview
5.14 ImpLite Ltd. Company Overview
5.15 Innovia LLC Company Overview
5.16 Lattice Medical Company Overview
5.17 LifeCell Corp Company Overview
5.18 Mentor Worldwide LLC Company Overview
5.19 Neosthetic, LLC Company Overview
5.20 Osteopore International Pte Ltd Company Overview
5.21 Plcoskin Company Overview
5.22 PolyNovo Biomaterials Pty Ltd Company Overview
5.23 Prayasta 3D Inventions Pvt Ltd Company Overview
5.24 Symatese Aesthetics Company Overview
5.25 Tensive SRL Company Overview
5.26 TeVido BioDevices LLC Company Overview

6 Breast Implants- Recent Developments
6.1 Mar 06, 2023: Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
6.2 Dec 16, 2022: MOXI and BBL treatments are now available at Chapin Aesthetics
6.3 Oct 13, 2022: The PSF receives FDA approval to conduct multicenter study of ADM and surgical mesh used in breast reconstruction
6.4 Sep 09, 2022: Breast Implants: Reports of Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Implants: FDA Safety Communication

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ptjg5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data